Malaysia (NPRA)
Safety Reporting and Pharmacovigilance Obligations to NPRA in 2026
Safety Reporting and Pharmacovigilance Obligations to NPRA in 2023 Safety Reporting and Pharmacovigilance Obligations to NPRA in 2023 This comprehensive tutorial serves as a guide for regulatory professionals involved in NPRA drug registration consulting in Malaysia. It details the step-by-step process regarding safety reporting and pharmacovigilance obligations mandated by the National Pharmaceutical Regulatory Agency (NPRA) for 2023. Step 1: Understanding NPRA’s Role in Drug Registration The National Pharmaceutical Regulatory Agency (NPRA) operates within the Ministry of Health Malaysia, tasked with ensuring the quality, safety, and efficacy of pharmaceuticals. Understanding NPRA’s role is fundamental in adhering to the regulatory obligations associated…